Abstract:Background: Organoids, which enable disease modeling and drug screening closer to an in vivo environment, can be isolated and grown from organs such as the brain, small intestine, kidney, lungs, and liver. To facilitate the establishment of liver and small intestinal organoids, we developed efficient protocols for cholangiocytes and intestine crypts collecting and organoid culturing. Methods: Cholangiocytes were collected from intrahepatic bile ducts, the gallbladder, and small intestine crypts by gravity settling and multistep centrifugation methods. The cells isolated were embedded with Matrigel and grew in three-dimensional spheroids in a suitable culture medium. The stability of organoid cells was assessed by subculture, cryopreservation, and thawing. RNA and DNA extraction of organoids, as well as immunostaining procedure, were also optimized. Hand-picking procedures were developed and performed to ensure similar growth characteristics of organoids. Results: A large number of cholangiocytes and small intestine crypts were collected under these protocols. Cholangiocytes developed into cyst-like structures after 3–4 days in Matrigel. After 1–2 weeks of cultivation, small intestinal organoids (in-orgs) developed buds and formed a mature structure. Compared to organoids derived from the gallbladder, cholangiocyte organoids (Cho-orgs) from intrahepatic the bile ducts grew more slowly but had a longer culture term, expressed the cholangiocytes markers Krt19 and Krt7, and recapitulated in vivo tissue organization. Conclusions: Our protocols simplified the cell collection procedure and avoided the possibility of exposing tissue-derived stem cells to mechanical damage or chemical injury by gravity settling and multistep centrifugation. In addition, our approach allowed similar growth characteristics of organoids from different mammalian tissue sources. The protocol requires 2–4 weeks to establish a stable organoid growth system. Organoids could be stably passaged, cryopreserved, and recovered under protocol guidance. Besides, the organoids of cholangiocytes and small intestines retained their original tissue characteristics, such as tissue-specific marker expression, which prepares them for further experiments such as preclinical in vitro trials and mechanism research studies.

Hormonally and chemically defined expansion conditions for organoids of biliary tree Stem Cells

Generation of liver bipotential organoids with a small-molecule cocktail

Mass Generation and Long-term Expansion of Hepatobiliary Organoids from Adult Primary Human Hepatocytes

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages

Bioengineered Tubular Biliary Organoids

Cell Isolation and Organoid Culture from Mouse Liver and Small Intestine

Establishment and long-term expansion of adult hepatobiliary organoids co-cultured with liver endothelial cells

Generation of hepatobiliary organoids from human induced pluripotent stem cells.

Development of a High-Throughput Micropatterned Agarose Scaffold for Consistent and Reproducible Hpsc-Derived Liver Organoids.

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Human Bile Contains Cholangiocyte Organoid-Initiating Cells Which Expand as Functional Cholangiocytes in Non-canonical Wnt Stimulating Conditions

Generation of human hepatobiliary organoids with a functional bile duct from chemically induced liver progenitor cells

3D Hepatic Organoid Production from Human Pluripotent Stem Cells

Patch grafting, strategies for transplantation of organoids into solid organs such as liver

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids

Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling

3D organoid cultivation improves the maturation and functional differentiation of cholangiocytes from human pluripotent stem cells

Patch Grafting of Stem/Progenitor Organoids, Strategies for Cell Therapies for Solid Organs, and Exemplified in Liver and Pancreas

Large‐Scale Production of LGR5‐Positive Bipotential Human Liver Stem Cells

Generation and metabolomic characterization of functional ductal organoids with biliary tree networks in decellularized liver scaffolds

Continuous Production of Highly Functional Vascularized Hepatobiliary Organoids from Human Pluripotent Stem Cells using a Scalable Microfluidic Platform